Trial intelligence / Profile preview

D-isoascorbic Acid + Arsenic Trioxide in Advanced Colorectal Cancer

NCT05721872Phase 2Unknown

Sponsor
Nazarbayev University
Start
Feb 2023
Primary completion
Aug 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Erythorbic acid in colorectal cancer (CRC), sponsored by Nazarbayev University. Status: unknown.

02

Drugs

Erythorbic acid
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT05721872.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05721872.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call